Preclinical studies suggest GLP-1 receptor agonists may reduce neuropathic pain through anti-inflammatory and neuroprotective effects
Adicionalmente, favorece respuestas aversivas, inhibidoras de la neuroinflamacin y del vaciamiento gstrico, as como estimuladoras del tono simptico y la termognesis en modelo experimental2,4,6
Jackson et al
The behavioral data is already measurable, among GLP-1 users, grocery spending is down 5.3%, savory snack spending is down 10.1%, QSR spending is down 8.0% and these are not rounding errors, are structural volume declines in categories that entire brand portfolios were built around
Clinically tested for skin irritation, its ideal for sensitive skin types
For the first time in my dieting history, I truly believe that this is going to be sustainable weight loss.